Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Randomized Experiments01:13

Randomized Experiments

9.3K
The randomization process involves assigning study participants randomly to experimental or control groups based on their probability of being equally assigned. Randomization is meant to eliminate selection bias and balance known and unknown confounding factors so that the control group is similar to the treatment group as much as possible. A computer program and a random number generator can be used to assign participants to groups in a way that minimizes bias.
Simple randomization
Simple...
9.3K
Bioequivalence Experimental Study Designs: Completely Randomized and Randomized Block Designs01:20

Bioequivalence Experimental Study Designs: Completely Randomized and Randomized Block Designs

368
Bioequivalence experimental study designs are crucial methodologies used in evaluating and comparing the bioavailability of different drug products. These designs are categorized into various types: completely randomized, randomized block, repeated measures, cross and carry-over, and Latin square designs.Completely randomized designs involve randomly allocating treatments to all subjects participating in the experiment. This allocation is achieved by assigning unique random numbers to subjects...
368
Bioequivalence Experimental Study Designs: Repeated Measures, Cross-Over, Carry-Over, and Latin Square Designs01:15

Bioequivalence Experimental Study Designs: Repeated Measures, Cross-Over, Carry-Over, and Latin Square Designs

384
Bioequivalence experimental study designs play a pivotal role in testing the effectiveness of various treatments. Key among these are the repeated measures, cross-over, carry-over, and Latin square designs. In the repeated measures design, each subject receives all treatments, allowing for temporal comparisons. This type of design is useful in reducing variability but requires careful planning to avoid bias.The cross-over design, an economical method, involves sequential administration of...
384
Blinding01:11

Blinding

4.1K
Blinding is a commonly used method of not telling participants which treatment a subject is receiving. Blinding is a critical part of a randomized control trial or RCT. It reduces the bias that affects the results. In an RCT, blinding is used in the form of a placebo. A placebo effect occurs when untreated subjects falsely believe they have received the treatment and report improved symptoms. A placebo or a dummy treatment is administered to subjects to negate the bias caused by such an effect.
4.1K
Blind Procedures02:07

Blind Procedures

13.9K
Ideally, the people who observe and record the children’s behavior are unaware of who was assigned to the experimental or control group, in order to control for experimenter bias. Experimenter bias refers to the possibility that a researcher’s expectations might skew the results of the study. Remember, conducting an experiment requires a lot of planning, and the people involved in the research project have a vested interest in supporting their hypotheses. If the observers knew which...
13.9K
Group Design02:01

Group Design

11.0K
The most basic experimental design involves two groups: the experimental group and the control group. The two groups are designed to be the same except for one difference— experimental manipulation. The experimental group gets the experimental manipulation—that is, the treatment or variable being tested—and the control group does not. Since experimental manipulation is the only difference between the experimental and control groups, we can be sure that any differences between...
11.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Concentration response analyses for QT data with several active compounds.

Journal of pharmacokinetics and pharmacodynamics·2026
Same author

A note on phase I interleaved versus parallel group ascending dose designs for concentration-QTc analyses.

Journal of pharmacokinetics and pharmacodynamics·2025
Same author

Using Confidence Distributions in Final and Interim Analyses for Single-Arm Studies or Platform Trials Consisting of Single-Arm Studies.

Statistics in medicine·2025
Same author

Why and how should we simulate platform trials? Learnings from EU-PEARL.

BMC medical research methodology·2025
Same author

Platform trial design for neurofibromatosis type 1, NF2-related schwannomatosis and non-NF2-related schwannomatosis: A potential model for rare diseases.

Neuro-oncology practice·2024
Same author

Exposure-response modeling for extrapolation from adult to pediatric patients who differ with respect to prognostic factors: Application to everolimus.

CPT: pharmacometrics & systems pharmacology·2021

Related Experiment Video

Updated: Mar 27, 2026

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
04:53

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition

Published on: September 20, 2019

11.5K

Randomization and allocation procedures for master protocol trials of single-arm studies.

Peter Jacko1,2, Günter Heimann3, Tom Parke2

  • 1Department of Management Science, Lancaster University, Lancaster, UK.

Statistical Methods in Medical Research
|March 25, 2026
PubMed
Summary
This summary is machine-generated.

This study introduces novel allocation methods for master protocol trials, enhancing efficiency for rare disease research. These procedures optimize participant assignment to accelerate study success and benefit patients faster.

Keywords:
allocation procedureclinical trialmaster protocolplatform designproof of conceptrandomizationrare diseasesimulationsingle-arm studyumbrella design

More Related Videos

Remotely Supervised Transcranial Direct Current Stimulation: An Update on Safety and Tolerability
08:22

Remotely Supervised Transcranial Direct Current Stimulation: An Update on Safety and Tolerability

Published on: October 7, 2017

8.6K
E-Patient Counseling Trial E-PACO: Computer Based Education versus Nurse Counseling for Patients to Prepare for Colonoscopy
06:28

E-Patient Counseling Trial E-PACO: Computer Based Education versus Nurse Counseling for Patients to Prepare for Colonoscopy

Published on: August 1, 2019

9.3K

Related Experiment Videos

Last Updated: Mar 27, 2026

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
04:53

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition

Published on: September 20, 2019

11.5K
Remotely Supervised Transcranial Direct Current Stimulation: An Update on Safety and Tolerability
08:22

Remotely Supervised Transcranial Direct Current Stimulation: An Update on Safety and Tolerability

Published on: October 7, 2017

8.6K
E-Patient Counseling Trial E-PACO: Computer Based Education versus Nurse Counseling for Patients to Prepare for Colonoscopy
06:28

E-Patient Counseling Trial E-PACO: Computer Based Education versus Nurse Counseling for Patients to Prepare for Colonoscopy

Published on: August 1, 2019

9.3K

Area of Science:

  • Clinical Trials Methodology
  • Biostatistics
  • Drug Development

Background:

  • Master protocol trials are efficient frameworks for evaluating multiple treatments.
  • Single-arm subtrials are often used in rare disease research due to limited patient populations.
  • Comparing single-arm data to external references (historical data, expert opinion) is common practice.

Purpose of the Study:

  • To propose and evaluate randomization and allocation procedures for master protocol trials with single-arm subtrials.
  • To investigate allocation strategies across various master protocol designs (umbrella, platform, perpetual).
  • To enhance the efficiency of master protocol trials, particularly for rare diseases.

Main Methods:

  • Development of novel participant allocation procedures based on predictive probability of success.
  • Simulation studies to assess the performance of proposed allocation methods.
  • Examination of allocation patterns in umbrella, platform, and perpetual master protocols.

Main Results:

  • Proposed allocation procedures demonstrate substantial efficiency gains in master protocol trials.
  • Optimized participant allocation leads to earlier study success declarations.
  • The methods effectively manage participant allocation in complex trial designs.

Conclusions:

  • Novel allocation procedures can significantly improve the efficiency of master protocol trials.
  • Predictive probability-based allocation accelerates the identification of successful treatments.
  • These advancements are particularly beneficial for rare disease research, improving patient outcomes.